참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Toluene | HCID 1140 | — |
| 반응물 | Dimethylformamide | HCID 6228 | — |
| 반응물 | Potassium Carbonate | HCID 11430 | — |
| 반응물 | 5-(Chloromethyl)-3-phenyl-1,2,4-oxadiazole | HCID 966714 | — |
| 반응물 | 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]piperazine | HCID 9974013 | — |
| 용매 | Water | HCID 962 | — |
| 생성물 | 1-[2-(Bis-(4-fluorophenyl)-methoxy)-ethyl]-4-(3-phenyloxadiazol-5-yl-methyl)piperazine | HCID 19106740 | — |
반응 단계
1.08 g (3.3 mM) of 1-[2-(bis-(4-fluorophenyl)-methoxy)ethyl]piperazine and 0.97 g of 3-phenyl-5-chloromethyl-1,2,4-oxadiazole (prepared according to Chem.Ber. 105 (1972)2825) were dissolved in 5 ml of dry dimethylformamide. 1.4 g of potassium carbonate were added and the mixture was stirred at room temperature overnight. Toluene and water were added, the aqueous phase extracted with toluene, the combined organic phases washed three times with water, treated with charcoal and evaporated in vacuo. The residue was dissolved in 10 ml of ethanol and 0.69 g of maleic acid were added. The precipitate was isolated by filtration and recrystallized from hot acetonitrile to obtain the dimaleate salt of the title compound as colourless crystals melting at 142°-143°. Analytical data were in accordance with the proposed structure.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US05276035 |
|---|
| 출처 데이터셋 | uspto-grants-1994_01 |
|---|
| ORD ID | ord-a9aa31526e9e43b3be5fba1f02c9e189 |
|---|
| 출처 메모 | uspto-grants-1994_01 |
|---|